Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


NANOIDENT Technologies AG announces new subsidiary, BIOIDENT Technologies Inc., in California
Company Opens U.S. Headquarters in Silicon Valley; Appoints Management Team

Menlo Park, Calif. —September 18, 2006—BIOIDENT Technologies Inc., a leading company in the development of printed semiconductor-based photonic lab-on-a-chip solutions for life sciences, today announced it has opened its headquarters in Menlo Park, Calif. The company also announced that it has appointed two executives who bring deep expertise in nanotechnology, printed organic semiconductors and biophotonics to BIOIDENT—Dr. Wasiq Bokhari, CEO and Dr. Max Sonnleitner, CTO.

BIOIDENT is the first and only company to leverage printed optoelectronics and microfluidics to create a new class of photonic lab-on-a-chip systems, which enable real-time, multiparameter detection and analysis capability for mobile field, diagnostic and point of care applications. BIOIDENT’s lab-on-a-chip systems will be used for mobile water and food analysis, chemical and biological agent detection and in-vitro diagnostics. These combined markets currently represent a $ 7.5 billion addressable opportunity for BIOIDENT.

Also announced today, BIOIDENT’s PhotonicLab™ Platform (see related release) will serve as the foundation for this new class of lab-on-a-chip systems with integrated on-chip photonic readout capabilities. The novel platform eliminates the need for external, expensive and bulky readout systems, enabling mobile analytics and diagnostics, immediate test results and a significant cost savings. These breakthrough lab-on-a-chip systems will also analyze multiple test parameters with a single chip in real time, substantially increasing testing efficiencies.

“BIOIDENT technology represents the ideal marriage of printed organic optoelectronic components and microfluidics, which will dramatically transform mobile diagnostic and infield analysis applications,” said Dr. Wasiq Bokhari, CEO for BIOIDENT. “For companies that provide analysis and diagnostic systems, BIOIDENT’s unique technology platform can address multiple applications, saving time and money for manufacturers and end customers.”

BIOIDENT is a subsidiary of NANOIDENT Technologies AG, the technology leader in the development and manufacture of organic semiconductor-based photonic solutions. NANOIDENT’s divisions include NANOIDENT ORGANIC FAB, GmbH and NANOIDENT Biometrics, GmbH. NANOIDENT’s extremely fast manufacturing process uses liquid conductive and semiconductive materials to print optoelectronic circuits on almost any surface using inkjet printing, producing products in minutes for both prototype and high volume applications.

“Early on, we recognized the impact that NANOIDENT technology could have for device manufacturers in the life sciences market. By forming a dedicated subsidiary in the U.S., we further the proliferation of NANOIDENT technology globally with the specific resources and expertise required for life sciences,” said Klaus G. Schroeter, CEO, NANOIDENT Technologies AG. “BIOIDENT’s new PhotonicLab™ Platform further specializes available NANOIDENT technology, enabling completely new mass markets for mobile analytics and mobile diagnostics.”

BIOIDENT Executive Team Members
Dr. Wasiq Bokhari, CEO
As CEO of BIOIDENT, Dr. Wasiq Bokhari will oversee BIOIDENT’s growth strategy as well as work to form new customer and partner relationships. Dr. Bokhari brings extensive entrepreneurial experience in adoption and commercialization of emerging materials and nanotechnology to BIOIDENT. Bokhari is a co-founder and Managing Partner of Quantum Insight, where he works with Fortune 500 and early-stage companies in the areas of lifesciences, energy and semiconductor applications. He serves as a business advisor to Chevron and is part of the team that has built and grown Molecular Diamond Technologies, a new nano-materials focused business unit. He also serves as a strategic advisor to Hitachi in the areas of emerging life sciences, electronics and energy applications. He was part of the founding team and interim CEO of Kalinex Inc., a drug discovery instrumentation co

Publisher Contact Information:

NANOIDENT Technologies AG
+1 650 391 4248

Company profile of NANOIDENT Technologies AG
Past press releases of NANOIDENT Technologies AG .


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Jan 17N/AIT services
Jan 17€7.4MInternet commerce
Jan 16€100.0MConsumer electronics
Jan 16€23.0MBiotechnology
Jan 15€1.2MEnergy related
Jan 15€28.0MKnowledge management

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.